New clinical cycloastragenol study released
There is a new study out on 97 humans, half taking 5 mg of cycloastragenol per day (less than one of our capsules).
It is also worth noting... even though this studies results are fantastic, it does not include our our higher dosage, or our UNIQUE DELIVERY SYSTEM which enables the maximum amount of the active ingredients are getting into your DNA (by-passing stomach acid and spreading the formula throughout the intestinal track).
This is a double blind professional clinical study published in Rejuvenation Research, a PubMed-indexed and peer-reviewed journal.
Over the course of one year the control group had a reduction in average telomere length and the cycloastragenol group had a significant increase in telomere length
Details in the the chart below.
Placebo Group A decrease in median telomere length over 12 months
| Group | Median telomere length over 12 months |
|---|---|
| Median telomere length | 290 ± 100 bp |
| 20th percentile telomere length | 170 ± 50 bp |
Cycloastragenol Group An increase vs placebo group in median telomere length over 12 months
| Group | Median telomere length over 12 months |
|---|---|
| Median telomere length | 533 ± 180 bp |
| 20th percentile telomere length | 270 ± 90 bp |
Published in Rejuvenation Research, a PubMed-indexed and peer-reviewed journal